Why the study?
Does slow-release nifedipine 20 mg/day improve hemodynamics and lower blood pressure in elderly hypertensives?
Does slow-release nifedipine 20 mg/day improve hemodynamics and lower blood pressure in elderly hypertensives?
Slow-release nifedipine effectively lowers blood pressure and peripheral resistance in elderly hypertensive patients without compromising regional blood flow or cardiac output.
Answers are grounded in this paper and cite their sources.
Supports cautious use of slow-release nifedipine in elderly hypertensives; leaves open outcome confirmation in randomized trials.
Ten elderly hypertensives (4 men, 6 women) were studied before and after 8-week administration of 20 mg/day slow-release nifedipine. Systemic and regional hemodynamic data were measured using a pulsed Doppler technique. Slow-release nifedipine reduced mean arterial pressure, while cardiac output remained unchanged, resulting in a decrease in total peripheral resistance. None of common carotid, vertebral, celiac, superior mesenteric, renal, or terminal aortic flow changed significantly before or after administration of slow-release nifedipine. Pharmacokinetic parameters were as follows: Cmax, 59.1 ng/ml; AUC, 288.2 ng hr/ml; Tmax, 3.4 hr; t1/2, 5.5 hr. There was a direct relationship between the concentration of slow-release nifedipine and its depressor effect. Slow-release nifedipine had no influence on humoral factors such as plasma renin activity, angiotensin II, aldosterone, atrial natriuretic peptide, noradrenaline or adrenaline. Slow-release nifedipine may provide desirable hemodynamic effects in elderly hypertensives.
No takes yet. Share an insight, caveat, or question.
Shimamoto et al. (1994) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: